For over 20 years, T2-weighted MR sequences have been used to detect signal in long T2 components of tissue. Tissues, however, also contain short T2 components, which until recently were not detectable on MR. New sequences such as magic angle imaging and ultrashort TE have for the first time detected signal from tendons, ligaments, menisci, periosteum, and cortical bone, according to Prof. Graeme Bydder, a radiologist formerly at Hammersmith Hospital in London and now at the University of California, San Diego.
For over 20 years, T2-weighted MR sequences have been used to detect signal in long T2 components of tissue. Tissues, however, also contain short T2 components, which until recently were not detectable on MR. New sequences such as magic angle imaging and ultrashort TE have for the first time detected signal from tendons, ligaments, menisci, periosteum, and cortical bone, according to Prof. Graeme Bydder, a radiologist formerly at Hammersmith Hospital in London and now at the University of California, San Diego.
"In addition, ultrashort TE can directly detect signals from very tightly bound water in other tissues, which previously could only be observed indirectly using magnetization transfer," Bydder said.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.